Todd M Tuttle Selected Research

Todd M Tuttle Research Topics

36	Neoplasms (Cancer) 10/2020 - 01/2002
32	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2002
9	Noninfiltrating Intraductal Carcinoma (DCIS) 11/2013 - 03/2004
8	Adenocarcinoma 01/2022 - 01/2011
6	Neoplasm Metastasis (Metastasis) 01/2022 - 12/2006
5	Melanoma (Melanoma, Malignant) 02/2021 - 02/2003
4	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 02/2014
4	Unilateral Breast Neoplasms 08/2019 - 11/2007
3	Stomach Neoplasms (Stomach Cancer) 09/2020 - 01/2011
2	Breast Carcinoma In Situ 02/2019 - 03/2009
2	Lymphatic Metastasis 11/2016 - 01/2011
2	Necrosis 11/2016 - 08/2012
2	Colonic Neoplasms (Colon Cancer) 01/2013 - 01/2008
2	Carcinoma (Carcinomatosis) 03/2010 - 01/2010
1	Cholangiocarcinoma 10/2020
1	End Stage Liver Disease 06/2020
1	Residual Neoplasm 01/2020
1	Incisional Hernia 01/2019
1	Ductal Carcinoma 08/2017
1	Colorectal Neoplasms (Colorectal Cancer) 01/2015
1	Wounds and Injuries (Trauma) 01/2013
1	Postoperative Pain 08/2012
1	Lobular Carcinoma 02/2012
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2011
1	Hyperglycemia 01/2011
1	Carcinoid Tumor (Carcinoid) 01/2011
1	Sarcoma (Soft Tissue Sarcoma) 07/2010
1	Hyperthermia 01/2008
1	Hypersensitivity (Allergy) 05/2004

12	Estrogen ReceptorsIBA 01/2022 - 10/2009
5	Tamoxifen FDA LinkGeneric 02/2010 - 09/2009
4	Progesterone Receptors (Progesterone Receptor)IBA 01/2019 - 01/2012
3	Coloring Agents (Dyes)IBA 07/2005 - 01/2002
2	SodiumIBA 06/2020 - 01/2011
2	human ERBB2 proteinIBA 08/2018 - 01/2018
2	Indicators and Reagents (Reagents)IBA 01/2013 - 11/2004
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2011 - 01/2008
2	Raloxifene Hydrochloride (Evista)FDA Link 02/2010 - 01/2010
2	Colloids (Colloid)IBA 07/2005 - 02/2005
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Epidermal Growth Factor (EGF)IBA 01/2019
1	ErbB Receptors (EGF Receptor)IBA 08/2017
1	InterferonsIBA 02/2014
1	Fluorouracil (Carac)FDA LinkGeneric 02/2014
1	Cisplatin (Platino)FDA LinkGeneric 02/2014
1	Estrogens (Estrogen)FDA Link 01/2012
1	Glucose (Dextrose)FDA LinkGeneric 01/2011
1	3- (4- amino- 3- methylbenzyl)- 7- (2- furyl)- 3H- (1,2,3)triazolo(4,5- d)pyrimidine- 5- amineIBA 07/2010
1	Aromatase InhibitorsIBA 01/2010
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 12/2006
1	SulfurIBA 02/2005
1	Choline (Choline Chloride)IBA 11/2004
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2004
1	iso-sulfan blue (Lymphazurin)FDA LinkGeneric 05/2004
1	Methylene Blue (Methylthioninium Chloride)FDA Link 05/2004
1	Technetium (Technetium 99m)IBA 01/2002

15	Radiotherapy 01/2021 - 03/2004
15	Therapeutics 06/2020 - 02/2003
13	Mastectomy (Mammectomy) 01/2021 - 03/2004
11	Prophylactic Mastectomy 08/2019 - 11/2007
8	Lymph Node Excision (Lymph Node Dissection) 02/2021 - 10/2002
8	Drug Therapy (Chemotherapy) 12/2020 - 11/2004
7	Adjuvant Chemotherapy 01/2022 - 09/2009
7	Segmental Mastectomy (Lumpectomy) 01/2021 - 10/2005
6	Hyperthermic Intraperitoneal Chemotherapy 01/2019 - 07/2006
4	Cytoreduction Surgical Procedures 01/2019 - 07/2006
3	Neoadjuvant Therapy 06/2020 - 11/2004
2	Catheters 11/2013 - 08/2012
2	Cholecystectomy 10/2009 - 04/2009
1	Sutures (Suture) 01/2020
1	Pancreatectomy 11/2016
1	Tissue Expansion Devices (Tissue Expander) 11/2016
1	Length of Stay 01/2013
1	Patient Readmission 01/2013
1	Operative Time 08/2012
1	Debridement 08/2012
1	Ovariectomy (Oophorectomy) 09/2011
1	Colectomy 01/2011
1	Appendectomy 01/2011
1	Gastrectomy 01/2011
1	Aftercare (After-Treatment) 06/2010
1	Esophagectomy 03/2010
1	Chemoprevention 01/2010
1	Intradermal Injections 12/2007
1	Proctectomy 02/2003
1	Operative Surgical Procedures 02/2003